Krsnaa Diagnostics Unlocks PET-CT Future with 15-Year Punjab Healthcare Mega-Deal
Context mode is active. Hover over any highlighted term to see its definition. Click a nested term to go deeper.
Krsnaa Diagnostics has made a significant strategic leap, entering the specialized PET-CT diagnostic services segment through a 15-year concession agreement with the Punjab Health Systems Corporation (PHSC). This landmark deal, announced on September 17, 2026, saw the company's shares jump as much as 11.4% on the day, signaling strong investor confidence in its expansion into high-end imaging for cancer care. The project involves developing, operating, and maintaining PET-CT facilities at four government hospitals across Punjab, marking a crucial step in Krsnaa's growth trajectory and India's healthcare infrastructure development. The move is particularly notable as Krsnaa Diagnostics previously approached the PET-CT segment cautiously, but has now committed due to surging demand for advanced oncology diagnostics and its proven track record in government partnerships. Operating under a Public-Private Partnership (PPP) model, specifically a Design, Build, Finance, Operate, Maintain, and Transfer (DBFOT) structure, the company's revenue will directly correlate with the number of scans performed, offering long-term visibility without an upfront fixed financial consideration. This aligns with Krsnaa's broader strategy of expanding its nationwide presence and integrating advanced diagnostic services, aiming to become one of Asia's largest radiology players. Looking ahead, this concession agreement is set to create a vital new revenue stream for Krsnaa Diagnostics, solidifying its position in India's rapidly expanding diagnostic market, especially in advanced cancer detection and monitoring. For Punjab, the partnership promises enhanced access to critical diagnostic services for its citizens, supported by the Department of Health & Family Welfare. This long-term commitment will undoubtedly shape Krsnaa's financial outlook for years to come, and its success could pave the way for similar high-value public-private collaborations in the country's healthcare sector.